SCHEMBL19637150

SCHEMBL19637150

CCc1c(C)nc([S+](C)[O-])nc1N(CC)CC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637172 0.68 HTT (0.32) HTT
SCHEMBL19637369 0.68 HTT (0.35) HTT
SCHEMBL19637255 0.66 HTT (0.34) HTT
SCHEMBL15904221 0.65 NOS3 (0.31) —
SCHEMBL19637079 0.64 HTT (0.32) HTT
SCHEMBL19592703 0.62 NUDT1 (0.39) —
SCHEMBL21895750 0.62 SMN1; SMN2 (0.41) HTT
SCHEMBL19491732 0.62 TTK (0.38) —
SCHEMBL19637432 0.61 KDM4E (0.36) —
SCHEMBL12483331 0.60 KDM4E (0.56) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
EP-3458445-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2021-02-17 — — EP disclosed
WO-2020101736-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2020-05-22 — — WO disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback